[The safety of Calcium channel blockers].
Leinonen
H
H
Department of Internal Medicine, Helsinki University Hospital, Helsinki, Finland.
D000367:Age Factors; D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D008134:Long-Term Care; D008297:Male; D009543:Nifedipine / Q000008:administration & dosage; D018570:Risk Assessment; D014700:Verapamil / Q000008:administration & dosage
D002121:Calcium Channel Blockers; D014700:Verapamil; D009543:Nifedipine